ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 250 filers reported holding ALKERMES PLC in Q4 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $411,000 | -44.0% | 8,087 | -12.5% | 0.01% | -87.7% |
| Q4 2015 | $734,000 | +184.5% | 9,243 | +110.4% | 0.06% | +39.0% |
| Q3 2015 | $258,000 | -86.4% | 4,393 | -85.1% | 0.04% | -46.1% |
| Q2 2015 | $1,903,000 | +158.2% | 29,567 | +144.6% | 0.08% | +162.1% |
| Q1 2015 | $737,000 | +108.2% | 12,090 | +99.5% | 0.03% | +61.1% |
| Q4 2014 | $354,000 | – | 6,059 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |